BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
253984
Number of visits today
60
Number of downloads
82183
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Bhattacharya S. Genotoxicity and in vitro investigation of Gefitinib-loaded polycaprolactone fabricated nanoparticles for anticancer activity against NCI-H460 cell lines. Journal of Experimental Nanoscience 2022;17:214-46. [DOI: 10.1080/17458080.2022.2060501] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Sherif AY, Harisa GI, Shahba AA, Alanazi FK, Qamar W. Optimization of Gefitinib-Loaded Nanostructured Lipid Carrier as a Biomedical Tool in the Treatment of Metastatic Lung Cancer. Molecules 2023;28. [PMID: 36615641 DOI: 10.3390/molecules28010448] [Reference Citation Analysis]
2 Li J, Zhu L, Kwok HF. Nanotechnology-based approaches overcome lung cancer drug resistance through diagnosis and treatment. Drug Resist Updat 2023;66:100904. [PMID: 36462375 DOI: 10.1016/j.drup.2022.100904] [Reference Citation Analysis]
3 Li N, Li G, Li R, Karmakar B, El-kott AF, Bani-fwaz MZ, Negm S, Morsy K. Synthesis of Au NPs/Quince nanoparticles mediated by Quince extract for the treatment of human cervical cancer: Introducing a novel chemotherapeutic supplement. mat express 2022;12:1465-1473. [DOI: 10.1166/mex.2022.2300] [Reference Citation Analysis]
4 Bhattacharya S, Singh D, Aich J, Ajazuddin, Shete MB. Development and characterization of Hyaluronic acid surface scaffolds Encorafenib loaded polymeric Nanoparticles for colorectal cancer targeting. Materials Today Communications 2022. [DOI: 10.1016/j.mtcomm.2022.103757] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345